Table 1 Patient demographics
Characteristic | Patients (n = 13) |
|---|---|
Age, median [range] | 73 [54–85] |
Gender, n (%) | |
 Male | 8 (62) |
 Female | 5 (38) |
ECOG performance status, n (%) | |
 0 | 7 (54) |
 1 | 6 (46) |
Prior lines of therapy, n (%) | |
 2 | 4 (31) |
 3 | 1 (8) |
  > 3 | 8 (62) |
Median prior lines [range] | 4 [2–9] |
Response to prior therapy, n (%) | |
 Refractory | 6 (46) |
 Relapsed | 4 (31) |
 Intolerant | 3 (23) |
Laboratory parameters, median [range] | |
 Creatinine clearance (mL/min) | 84 [41–176] |
 β2 microglobulin (mg/L) | 4.7 [2.0–13.6] |
 Albumin (g/L) | 35 [29–45] |
 Paraprotein (g/L) | 15 [0–52] |
 Kappa FLC (mg/L) | 154 [5.2–1764] |
 Lambda FLC (mg/L) | 5.8 [0.4–314] |